Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)

Market Cap	3.58B
Revenue (ttm)	1.78B
Net Income (ttm)	43.25M
Shares Out	552.92M
EPS (ttm)	0.08
PE Ratio	82.84
Forward PE	n/a
Dividend	0.03 (0.43%)
Ex-Dividend Date	n/a

Volume	12,092,700
Average Volume	16,431,756
Open	6.47
Previous Close	6.47
Day's Range	6.39 - 6.48
52-Week Range	4.51 - 7.32
Beta	0.80
RSI	45.80
Earnings Date	Oct 30, 2025

About SHA:600222

Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the research, development, and sale of pharmaceutical preparations and Chinese herbal medicines in China. Its principal products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, Danshen oral liquid, pediatric heat-clearing and cough-relieving oral liquid, pediatric compound chicken gizzard chewable tablets, and Huperzine A tablets. The company serves hospitals, primary medical institutions, and retail terminals. The company was formerly known as Henan Joyline & Joysun Pharma...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 2,214
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600222

Financial Performance

In 2024, SHA:600222's revenue was 1.94 billion, a decrease of -6.21% compared to the previous year's 2.07 billion. Earnings were 50.53 million, an increase of 16.00%.